Microbicide Research, Development, and Introduction, Round 2: Advancing the Microbicide Pipeline

To advance promising ARV-based microbicides through preclinical and early-/mid-stage clinical testing.

This project includes the following aims: Advance DS003-based tablet and ring through Phase I/II clinical evaluation; Advance maraviroc and maraviroc-combination rings through formulation and preclinical development; and, Identify and evaluate new and early development ARV compounds with alternative mechanisms of action for pipeline progression.